24 65

Cited 0 times in

Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease?

DC FieldValueLanguage
dc.contributor.author박지혜-
dc.contributor.author천재희-
dc.contributor.author천재희-
dc.date.accessioned2021-09-29T05:33:09Z-
dc.date.available2021-09-29T05:33:09Z-
dc.date.issued2021-09-
dc.identifier.issn1976-2283-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/185094-
dc.description.statementOfResponsibilityopen-
dc.languageEnglish-
dc.publisherEditorial Office of Gut and Liver-
dc.relation.isPartOfGUT AND LIVER-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleCan Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease?-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorJihye Park-
dc.contributor.googleauthorJae Hee Cheon-
dc.identifier.doi10.5009/gnl210345-
dc.contributor.localIdA04575-
dc.contributor.localIdA04030-
dc.contributor.localIdA04030-
dc.relation.journalcodeJ00954-
dc.identifier.eissn2005-1212-
dc.identifier.pmid34521776-
dc.contributor.alternativeNamePark, Ji Hye-
dc.contributor.affiliatedAuthor박지혜-
dc.contributor.affiliatedAuthor천재희-
dc.contributor.affiliatedAuthor천재희-
dc.citation.volume15-
dc.citation.number5-
dc.citation.startPage641-
dc.citation.endPage642-
dc.identifier.bibliographicCitationGUT AND LIVER, Vol.15(5) : 641-642, 2021-09-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.